The largest database of trusted experimental protocols

0.22 μm syringe filter

Manufactured by Pall Corporation
Sourced in United States

The 0.22 μm syringe filter is a laboratory filtration device designed to remove particulates and microorganisms from liquid samples. It features a 0.22 μm pore size membrane that effectively retains bacteria and other small particles, ensuring the filtrate is free from contaminants.

Automatically generated - may contain errors

6 protocols using 0.22 μm syringe filter

1

Copolymer-Based RNA Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lyophilized copolymers
were dissolved into ethanol at 50 mg/mL and stored at 4 °C. This
stock was further diluted to 3.33 mg/mL in citric acid buffer (pH
4, 100 mM) and rapidly mixed with 3pRNA or OH-RNA at charge ratios
(N:P) between 20:1 and 1:1. After incubating at room temperature for
30 min, 1.24× volume phosphate buffer (pH 8, 100 mM) was added
and mixed rapidly to form nanoparticles (NPs). After 15 min, the solution
was further diluted into 1× PBS (pH 7.4, Gibco) before use. The
second block DMAEMA content is estimated to have 50% protonation for
the purposes of determining N:P ratios. A charge ratio of 20:1 was
selected for all in vitro cell culture studies. The
same approach was used to prepare formulations for in vivo studies, except that they were suspended at 10 mg/mL in citric acid
buffer instead of 3.33 mg/mL, phosphate buffer was added at a ratio
of 1:1.26, a charge ratio of 15:1 was used, and formulations were
filtered using a 0.22 μm syringe filter (Pall corporation).
3pRNA complexation efficiency was determined by quantifying free 3pRNA
after NP/3pRNA formulation with the fluorescence-based RiboGreen reagent
(Invitrogen) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Purification of Bispecific Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration of parental antibodies in culture media was quantitated via Biolayer Light Interferometry (BLI) using ForteBio anti-human Fab-CH1 second Generation (FAB2G) biosensors on an Octet RED96 instrument (ForteBio; Pall Life Sciences, Fremont, CA, USA). Then, cultures from F405L and K409R RF constructs were mixed at a ratio of 1:1.2 and then reduced using 75 mM of β-mercaptoethanol (βME) for 5 h at 31 °C before dialysis in phosphate-buffered saline(PBS) at 4 °C overnight with Slide-A-Lyzer™ Dialysis Flasks, 10K molecular weight cut-off (MWCO), 250 mL (Thermo Scientific™, Waltham, MA, USA). Antibodies were then affinity purified using 5mL MabSelect™ SuRe™ (General Electric Healthcare, Chicago, IL, USA) using the manufacturer’s specifications. After elution, bsAbs were filtered using a 0.22 μm syringe filter (Pall Corporation, New York, NY, USA).
+ Open protocol
+ Expand
3

Conditioned Media Characterization and Modification

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSC- or MDF-derived CM was harvested 3 days post incubation. For some experiments, CM was subjected to some modifications; CM was filtered using a 0.22-μm syringe filter (Pall Corporation, Port Washington, NY, USA); filtered CM was heat-inactivated at 100 °C for 5 min; CM was treated with different doses (15–60 μM) of compstatin (TOCRIS, Bristol, UK), which is a C3 inhibitor; CM was separated using filter units with a molecular weight cutoff size of 50 or 100 kDa (Millipore, Billerica, MA, USA). For FPLC separation and western blot analysis, 200 ml of filtered CM, which was harvested 3 days post incubation in the absence of serum, were concentrated (200 × ) using filter units with a molecular weight cutoff size of 50 kDa. For ER/Golgi block, cells were incubated for 24 h with 2 μM of monensin (Sigma, St. Louis, MO, USA), which blocks the protein transport from the endoplasmic reticulum to the Golgi apparatus. Then, CM was harvested and filtered by using a 0.22-μm syringe filter.
+ Open protocol
+ Expand
4

Quantifying Brain Dopamine Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripubertal and young adult mice were euthanized and their brain tissue was dissected and snap-frozen using liquid nitrogen. Samples were sonicated in 200μL of 0.1N perchloric acid and, after centrifugation at 14,000xg for 15 minutes, the supernatant was filtered through a 0.22μm syringe filter (PALL Corp). Tissue levels of dopamine were measured by HPLC analysis coupled with electrochemical detection as described16 (link). Fast isocratic separation was obtained using a reverse phase TSK gel Super-ODS C-18 column (4.6mm x 100mm, 2μm particle size; Tosoh Bioscience) with the following mobile phase: 30mM sodium citrate, 13.7mM sodium monobasic phosphate, 0.025mM Na2EDTA, 0.75mM sodium octanesulphonate; pH 3.15-3.2, containing 0.6 % tetrahydrofuran, 0.1% diethylamine, and 6.5% acetonitrile.
+ Open protocol
+ Expand
5

Bacterial Culture Broth Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain bacterial culture broths, different strains of Photorhabdus or Xenorhabdus bacteria were cultured in 100 mL of LB for 48 h at 28°C until OD600 reached 2.0. The culture medium was then centrifuged at 8000 r/min for 20 min. The supernatant was collected and filtered through 0.22 μm syringe filter (Pall Corp., Ann Arbor, MI, United States) to remove bacterial cells.
+ Open protocol
+ Expand
6

Radiolabeling and Characterization of 18F-FAPI-04

Check if the same lab product or an alternative is used in the 5 most similar protocols
18F-FAPI-04 was prepared as described previously (17 (link),18 (link)). The NOTA-FAPI-04 precursor was purchased from Beijing PET Technology Co. Ltd. 18F was produced from a medical cyclotron (Siemens Medical Solutions). The synthesis of 18F-FAPI-04 was performed in an AllInOne synthesis module (Trasis). The final product was reconstituted in saline and passed through a 0.22-μm syringe filter (Pall Corp.). The radiochemical purity of 18F-FAPI-04 was analyzed by radio–high-performance liquid chromatography (1200 series; Agilent) and was more than 95%. 18F-FDG was synthesized automatically and routinely in a 18F-FDG synthesizer module (FDG4 Explora; Siemens) and was purified to radiochemical purity of more than 95% before clinical use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!